Connect with us

News

Praise, criticism as HRC heads into new era

Some laud Solmonese for state focus, others say marriage crowding out other priorities

Published

on

Joe Solmonese @ Hill press conference 2009 by Michael Key

HRC President Joe Solmonese will step down at the end of March.(Washington Blade file photo by Michael Key)

The Human Rights Campaign’s search for a new president began in full force on Nov. 22 when an executive recruiting firm retained by the HRC board issued an eight-page job announcement describing the qualifications and experience sought for the next leader of the nation’s largest LGBT advocacy group.

The release of the job announcement, which is posted on the HRC website, followed an Oct. 3 announcement by HRC that its board had retained Russell Reynolds Associates, a nationally known executive recruitment firm, to assist the board in its search for the replacement of Joe Solmonese.

Solmonese has held the post of president and CEO of HRC and the HRC Foundation since 2005. He announced in August that he would step down from his position when his current contract expires on March 30, 2012.

“The entire HRC board understands the importance of this search to our community, to our continued progress as a movement and to our organization,” said HRC Board Co-Chair Rebecca Tillet.

“That’s why we will run a process that is inclusive and respects the importance of diversity in the candidate pool,” said Andy Linsky, co-chair of the board of the HRC Foundation, HRC’s research and educational arm.

Since Solmonese announced he was stepping down, LGBT activists have been debating HRC’s role in the movement its effectiveness during Solmonese’s tenure.

In an informal survey of LGBT activists in Washington and across the country over the past week, the Blade has found that most believe HRC has done a good job of advocating for LGBT equality on the federal and state level. Leaders of at least seven state and local LGBT organizations said HRC worked cooperatively with their respective groups on joint projects.

Others, including two nationally recognized transgender rights advocates, expressed concern that HRC – as well as other national LGBT organizations – have devoted too much of their time and resources to same-sex marriage efforts at the expense of pushing for non-discrimination laws on the federal, state and local levels. Those expressing this position say non-discrimination laws would have a beneficial impact on far more LGBT people than laws seeking to legalize same-sex marriage.

While they don’t object to spending resources on marriage equality, those expressing this view say HRC and other national LGBT groups are devoting far too little attention to non-discrimination measures, including the Employment Non-Discrimination Act or ENDA, a bill pending in Congress that would ban employment discrimination based on sexual orientation and gender identity.

“I hope the HRC board of directors thinks about this,” said Mara Keisling, executive director of the National Center for Transgender Equality. “They do some very great things. But they are moving in the direction of marriage being their primary focus,” she said.

Keisling’s view was echoed by Maryland transgender advocate Dana Beyer, a former HRC board member, who said HRC appears to be evolving into a “marriage all the time” organization.

HRC officials have said it is devoting its resources to a wide range of programs and projects in addition to marriage equality. They say many of the projects are aimed at changing the minds of voters and lawmakers in an effort to line up the small number of additional votes in the U.S. House and Senate needed to pass ENDA.

Rep. Barney Frank (D-Mass.), the gay lawmaker and lead sponsor of ENDA in the House, has said the bill has no chance of passing until Democrats regain control of the House. Frank says Republican House leaders won’t allow the bill to come up for a vote, even though a sizable number of House Republicans are expected to vote for ENDA.

HRC supporters acknowledge that many in the LGBT community have questioned HRC’s capabilities and effectiveness, often fueled by HRC critics who say the group hasn’t been able to secure passage of ENDA. Some critics say HRC should have done more 2009 and 2010, when Democrats controlled the House and Senate with a Democratic president in the White House.

Arlington, Va., gay activist Bob Mialovich, an HRC member and contributor who retired recently as a federal government official, called such criticism unfair.

“I can understand peoples’ frustration, but the reality is we don’t have a majority of support in Congress to pass the bills we need to pass,” he said. “If you are not directly involved, you may not be aware of what HRC is doing. What I know is they are doing a lot.”

HRC spokesperson Fred Sainz has said HRC played a key role, along with other gay advocacy groups, in lobbying for passage of the Matthew Shepard and James Byrd, Jr. Hate Crimes Prevention Act, which authorizes the federal government to prosecute hate crimes targeting LGBT people. Sainz also points to the success HRC and its partner groups have had in lobbying for repeal of “Don’t Ask, Don’t Tell.”

He said HRC worked closely with other groups to facilitate the Obama administration’s issuance of a large number of regulatory changes and federal agency rules that ban discrimination against LGBT people in healthcare, housing and other areas.

In addition to lobbying Congress, the White House and state and local governments on LGBT supportive bills and policies, and its election-related work on behalf of LGBT supportive candidates, HRC supporters point to a wide range of projects carried out by the HRC Foundation. Among them is the HRC Corporate Equality Index, which rates the nation’s Fortune 500 companies on whether their internal personnel policies ban discrimination based on sexual orientation and gender identity.

In its latest criteria for companies to obtain HRC’s highest rating in the Corporate Equality Index, the group raised the bar by calling for companies to include gender reassignment surgery for transgender employees in the companies’ health insurance plans. A large number of them have agreed to do so.

Other projects include a Healthcare Equality Index, which rates hospitals and other healthcare facilities on their treatment of LGBT people; a Welcoming Schools Program, that pushes for anti-bullying and other LGBT-supportive school policies; an All Children-All Families project that trains and sensitizes adoption agencies on LGBT families; and a Religion and Faith Program, which encourages LGBT-supportive clergy to speak out on LGBT issues, including same-sex marriage efforts.

Another program trains LGBT students enrolled in the nation’s historically black colleges to become student leaders in an effort to advance LGBT equality on their campuses.

HRC supporters also point to the group’s aggressive press and communications operation, which responds quickly and on a 24-hour basis to breaking developments by providing the media with statements and information on a wide range of issues, including responses to anti-LGBT groups or public officials.

The group’s 990 IRS finance report for 2010, the most recent one filed, shows that HRC and the HRC Foundation had a combined income of $39.8 million for the fiscal year running from April 1, 2010 to March 31, 2011.

With a staff of 150 full-time employees, the group’s revenue of close to $40 million makes HRC the largest national LGBT advocacy group. The group also owns its own office building in downtown Washington, an investment HRC officials and supporters have said helps the group advance its mission.

The building, among other things, houses a community event space that HRC calls the Equality Center, which often is used by local D.C. area LGBT organizations. The building includes a multimedia production facility. HRC says the building also generates income through the renting of surplus office space to outside groups and firms. The D.C. Office of Tax and Revenue has assessed the value of the building for 2012 at $16.6 million, an increase from its 2011 assessed value of $14.4 million.

‘Surplus of ill will’

Despite its income and broad range of programs, some critics say HRC has worked at cross purposes with other national and state LGBT organizations. In a development that created a stir among some activists, veteran gay rights advocate Matt Foreman, the former executive director of the National Gay and Lesbian Task Force and former head of New York’s statewide LGBT group Empire State Pride Agenda, wrote a strongly worded critique of HRC that was published last month in two widely read LGBT blogs.

“The reality is that we are two separate movements: the Human Rights Campaign and everyone else,” Foreman wrote. He said that while HRC and its leaders and staff have accomplished many important things, “the cause of LGBT equality has suffered because of a deficit of trust and a surplus of ill will between HRC and the rest of the movement.”

Foreman did not respond to a call from the Blade seeking to discuss further his criticism of HRC.

Leaders of statewide LGBT advocacy groups contacted by the Blade in California, Illinois, Texas, Georgia, Florida, Pennsylvania and D.C. each said they have an amicable working relationship with HRC. Although they declined to comment directly on Foreman’s views about HRC, the officials said it was not uncommon for LGBT advocates to disagree over strategy and tactics but that the groups they work with – including HRC – have always worked through the disagreements.

Rebecca Isaacs, the recently named executive director of the Equality Federation, a national group that represents LGBT advocacy organizations in the states, has been involved in LGBT movement groups on the national level since the 1980s, including her role as political director for the National Gay and Lesbian Task Force.

“HRC is part of the world of people with expertise on a lot of things,” Isaacs said, adding that Equality Federation is working with HRC on a number important issues occurring in the states. “We are dealing with 50 states, each with different people doing different things. My question is who wants to help? I’m not in any camp.”

Bil Browning, publisher of the Bilerico Project, an LGBT blog that published Foreman’s commentary criticizing HRC, said he was among HRC’s strongest critics in past years. But he said he has seen what he considers a major change for the better by HRC under Solmonese’s leadership.

Among other things, Browning said Solmonese greatly improved HRC’s relations with state LGBT organizations and significantly boosted HRC support for state and local initiatives. He said he saw this first hand as one of the leaders of the state LGBT group in Indiana, where Browning lived before moving to D.C.

According to Browning, HRC provided him with important support when he coordinated a successful effort to pass a non-discrimination ordinance in Indianapolis that includes protections for LGBT people.

“And as Indiana was fighting its marriage amendment battle, who was one of the first groups to stand up and say do you need cash, do you need polling, what do you need? It was HRC,” Browning said.

“I have to admit that for all my quibbles with HRC and some of the various stuff that they’ve done over the years, LGBT rights wouldn’t be as far as it is in Indiana without them,” he said.

Veteran gay Democratic activist Peter Rosenstein of D.C. was among some activists who viewed Foreman’s criticism as reflecting disagreements within the LGBT movement over tactics and strategy.

“While I agree with some of what Matt Foreman writes I think he needs to take some personal responsibility for the movement not being in sync,” said Rosenstein. “As he says, he had the opportunity to lead a national organization and it sounds like he still wants all things his way. I have often criticized HRC and I agree they should be more open and work more closely with the larger LGBT community. My hope is that they first do a truly open and wide ranging search for a replacement for Joe Solmonese.”

Longtime D.C. gay and Ward 8 community activist Phil Pannell, who has advocated for LGBT support within the city’s African-American community, said he’s been an HRC member for many years and thinks HRC does good work on the local and national level.

“I have seen HRC reach out the black community,” he said.

Rick Rosendall, vice president of the Gay and Lesbian Activists Alliance of Washington, D.C., said he is troubled over what he called “internecine sniping” over HRC in the LGBT movement.

“The reality is that all LGBT activists and donors do not share the same goals, priorities and approaches.” He said GLAA and HRC “haven’t always seen eye to eye, but we have had a mutually respectful and productive relationship for many years.”

He added, “HRC does a lot of useful things, but if someone doesn’t like them, there are plenty of other groups to support…. HRC has a large and loyal donor base, and its headquarters is not going to crumble because of one more harsh op-ed. Any movement as diverse as ours is inherently messy. Deal with it, folks.”

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

Rehoboth Beach

Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands

$4.5 million listing includes real estate; business sold separately

Published

on

The real estate at Rehoboth’s Blue Moon is for sale for $4.5 million. (Washington Blade photo by Michael Key)

Gay gasps could be heard around the DMV earlier this week when a real estate listing for Rehoboth Beach’s iconic Blue Moon bar and restaurant hit social media.

Take a breath. The Moon is for sale but the longtime owners are not in a hurry and are committed to preserving its legacy as a gay-friendly space.

“We had no idea the interest this would create,” Tim Ragan, one of the owners, told the Blade this week. “I guess I was a little naive about that.”

Ragan explained that he and longtime partner Randy Haney are separating the real estate from the business. The two buildings associated with the sale are listed by Carrie Lingo at 35 Baltimore Ave., and include an apartment, the front restaurant (6,600 square feet with three floors and a basement), and a secondary building (roughly 1,800 square feet on two floors). They are listed for $4.5 million. 

The bar and restaurant business is being sold separately; the price has not been publicly disclosed. 

But Ragan, who has owned the Moon for 20 years, told the Blade nothing is imminent and that the Moon remains open through the holidays and is scheduled to reopen for the 2026 season on Feb. 10. He has already scheduled some 2026 entertainment. 

“It’s time to look for the next people who can continue the history of the Moon and cultivate the next chapter,” Ragan said, noting that he turns 70 next year. “We’re not panicked; we separated the building from the business. Some buyers can’t afford both.” 

He said there have been many inquiries and they’ve considered some offers but nothing is firm yet. 

Given the Moon’s pioneering role in queering Rehoboth Beach since its debut 44 years ago in 1981, many LGBTQ visitors and residents are concerned about losing such an iconic queer space to redevelopment or chain ownership.

“That’s the No. 1 consideration,” Ragan said, “preserving a commitment to the gay community and honoring its history. The legacy needs to continue.” He added that they are not inclined to sell to one of the local restaurant chains.

You can view the real estate listing here.

Continue Reading

Popular